Table 2 HIV associated clinical and laboratory characteristics of 440 study participants
Variable | Mean (SD)/Median (IQR)/n (%) |
|---|---|
Use of Cotrimoxazole prophylaxis | |
Yes | 397 (90.2) |
No | 43 (9.8) |
Duration on ART (years) | |
< 1 | 82 (18.6) |
1–2 | 69 (15.7) |
> 2 | 289 (65.7) |
Baseline CD4 count (N = 414) | |
Mean | 215.1 (±152.6) |
< 200 | 197 (47.5) |
200–349 | 159 (38.4) |
350–500 | 42 (10.1) |
> 500 | 16 (3.9) |
Current CD4 count (N = 396) | |
Mean | 579.6 (±203.0) |
< 200 | 9 (2.3) |
200–349 | 33 (8.3) |
350–500 | 94 (23.7) |
> 500 | 260 (65.7) |
Plasma viral load after 6 months on ART (N = 317) | |
Median | 1080 (198, 2598) |
0 | 2 (0.6) |
< 1000 | 147 (46.4) |
≥ 1000 | 168 (53.0) |
Plasma viral load after 12 months on ART (N = 411) | |
Median | 90 (20, 328) |
0 | 85 (20.7) |
< 1000 | 283 (68.9) |
≥ 1000 | 43 (10.5) |